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The molecularly cloned viruses known as SIVmac239/
R17Y and SIVmac239/YEnef cause extensive lymphocyte
activation and induce an acute disease syndrome in
macaque monkeys. One manifestation of this syndrome
is a severe diffuse cutaneous maculopapular exanthem
that is similar to the exanthem associated with HIV-1
infection. To examine the pathogenesis of this exanthem,
biopsies obtained throughout the course of clinically
evident rash were examined for the presence of virus by
in situ hybridization and immunohistochemistry, and the
cellular infiltrate was characterized with respect to cellular
immunophenotype and chemokine receptor expression.
The onset of rash was associated with abundant simian
immunodeficiency virus nucleic acid and protein within
perivascular dermal infiltrates and occasionally within
The acute exanthem associated with primary humanimmunodeficiency virus (HIV) infection is one of manyclinical symptoms associated with the mononucleosis-like illness that arises prior to seroconversion (Cooperet al, 1985). Other common manifestations are fever,
malaise, myalgia, headache, pharyngitis, and lymphadenopathy (Cooper
et al, 1985; Lindskov et al, 1986). HIV exanthem is the most common
of these clinical syndromes, occurring in up to 70% of patients during
primary HIV-1 infection (Clark et al, 1991; Kinloch-de Loes et al,
1993; Fiscus et al, 1995; Lapins et al, 1996). This nonpruritic roseola-
like rash consists of round to oval erythematous macules and papules
localized mostly to the trunk, with the face and extremities as the
second and third most common sites affected (Berger et al, 1988;
McMillan et al, 1989; Kinloch-de Loes et al, 1993; Alessi and Cusini,
1995; Duvic, 1995; Goldman et al, 1995; Lapins et al, 1996; Martinez-
Escribano et al, 1996). Histopathologic examination of skin lesions has
shown a perivascular lymphohistiocytic infiltrate of the superficial
dermis with epidermal spongiosis and parakeratosis (McMillan et al,
1989; Balslev et al, 1990; Hulsebosch et al, 1990; Goldman et al,
1995; Lapins et al, 1996; Martinez-Escribano et al, 1996). These
histopathologic and immunohistologic features of HIV exanthem are
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intraepithelial cells. Analysis of cellular infiltrates showed
that biopsies, obtained on the day of rash onset, were
composed of equal numbers of CD4F and CD8F
lymphocytes and abundant aEb7 positive cells sur-
rounding vessels with upregulated endothelial E-selectin.
Moreover, by examining virus expression in sequential
skin biopsies from the same animal, the clearance of
virus and the resolution of rash were associated with an
increase in the percentage of cells expressing CD8, the
chemokine receptor CXCR3, and GMP-17, a marker of
cytotoxic granules. These results suggest that activated
cytotoxic T cells are trafficking to sites of inflammation
in the skin and directly or indirectly affect levels of viral
replication at these sites. Key words: CXCR3/lymphocyte/
rash/skin. J Invest Dermatol 110:894–901, 1998
not unique to HIV infection and resemble those of other viral infections
(McMillan et al, 1989; Balslev et al, 1990; Duvic, 1995). Moreover,
although this acute syndrome is associated with high levels of viremia
(Clark et al, 1991; Daar et al, 1991), HIV is not uniformly observed
in skin lesions (McMillan et al, 1989; Duvic, 1995; Lapins et al, 1996).
Hence, the pathogenesis of this exanthem remains an enigma.
To investigate the pathogenesis of the HIV exanthem, investigators
have used the simian immunodeficiency virus (SIV)-infected macaque
monkey model of AIDS (Ringler et al, 1986, 1987; Baskin et al, 1988).
SIV is a lentivirus that has similar genomic organization and gene
sequences to HIV (Desrosiers, 1990) and induces both acute and AIDS-
like disease syndromes in macaque monkeys (Letvin et al, 1985;
Reimann et al, 1994). Within a few weeks of infecting macaque
monkeys with most strains of SIV, an erythematous maculopapular
eruption can occur, which is histologically identical to that described
in primary HIV-1 infection (Ringler et al, 1986, 1987; Baskin et al,
1988). As with HIV exanthem, the virus has not been demonstrated
in biopsies obtained from SIV-infected macaques with skin rash (Ringler
et al, 1986, 1987; Baskin et al, 1988). Recently it has been shown that
the single or double amino acid substitution (R with Y at position 17
or RQ with YE at positions 17 and 18) in the nef gene of the molecular
clone SIVmac239 resulted in an exaggerated acute disease syndrome,
including earlier onset and more severe maculopapular rash than that
observed with wild-type virus (Du et al, 1995, 1996; Sasseville
et al, 1996a).
Here we describe the viral localization and histopathologic and
immunophenotypic changes in sequential skin biopsies obtained from
six rhesus monkeys infected with these acutely pathogenic clones of
SIVmac239. We demonstrate that the onset of rash is earlier than that
observed with other strains of SIV and is associated with cellular
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infiltrates containing abundant SIV nucleic acid and protein. Perivascu-
lar cellular infiltrates within skin biopsies, obtained on the day of
rash onset, are composed of equal numbers of CD41 and CD81
lymphocytes and abundant αEβ7 positive cells surrounding vessels
with upregulated endothelial E-selectin, which is compatible with
active recruitment of memory T cells to the skin. Moreover, by
examining sequential skin biopsies from the same animal, we show
that clearance of virus and resolution of rash is associated with an
increase in the percentage of perivascular inflammatory cells expressing
CD8, the chemokine receptor CXCR3, and GMP-17, a marker of
cytotoxic granules. These results suggest that activated cytotoxic T
cells are trafficking to sites of inflammation in the skin and directly or
indirectly affect levels of viral replication at these sites.
MATERIALS AND METHODS
Animals and viral infections Eighteen rhesus macaques were infected with
either SIVmac239YEnef or SIVmac239/R17Y. Twelve rhesus monkeys were
infected with SIVmac239/YEnef (50 ng p27) containing a single NF-κB
binding element and two each with SIVmac239/R17Y (300 ng p27) containing
zero, one, and two NF-κB elements. The presence of variable numbers of NF-
κB elements has no detectable effect on disease course (Du et al, 1996).
Inoculations were by the intravenous route and two animals from the
SIVmac239/YEnef-infected group were killed by an intravenous overdose of
sodium pentobarbital at days 3, 7, 14, and 21 post-infection (pi) and three at
day 50 pi. Two animals from the SIVmac239/R17Y-infected group were killed
by an intravenous overdose of sodium pentobarbital at day 9 and three at day
10. In addition to these time points, one of the SIVmac239/YEnef-infected
animals (Mm41–76) and one of the SIVmac239/R17Y-infected animals
(Mm204–84) became moribund and were killed at days 12 and 8 pi, respectively.
Details of the viral constructs, disease course, pathology, and viral localization
in tissue other than skin have been previously published (Du et al, 1995, 1996;
Sasseville et al, 1996a). All animals were negative for antibodies to SIV, Type
D retrovirus, and simian T cell leukemia virus type 1 (STLV-1). Animals
were housed in accordance with standards of the American Association for
Accreditation of Laboratory Animal Care. The investigators adhered to the
‘‘Guide for the Care and Use of Laboratory Animals’’ prepared by the Committee
on Care and Use of Laboratory Animals of the Institute of Laboratory Resources,
National Research Council.
Virus and virus isolation SIVmac239/YEnef and SIVmac239/R17Y have
been described previously (Du et al, 1995, 1996). Virus stocks for animal
inoculations were produced by transfection of cloned DNA into CEMX174
cells as described in Gibbs et al (1994). Peripheral blood was collected prior to
inoculation and at days 3, 7, and weekly after inoculation. Infectious virus was
isolated from blood by cocultivation of 5 3 106 CEMX174 cells with at least
4 3 106 peripheral blood mononuclear cells as described previously (Desrosiers
et al, 1989). Culture supernatants were tested biweekly for SIV by p27 capture
enzyme-linked immunoassay (Coulter, Miami, FL).
Flow cytometry Two-color flow cytometric analysis of peripheral blood T
cell subsets was performed in the SIVmac239/YEnef-infected animals using a
whole blood cell lysis technique as described previously (Veazey et al, 1997).
One milliliter of heparinized blood from each animal was incubated for 45 min
at 4°C with monoclonal antibodies against CD4 (OKT4, Ortho Diagnostics
Systems, Raritan, NJ) and CD8 (Leu-2a, Becton Dickinson, San Jose, CA)
directly conjugated to either fluorescein isothiocyanate, phycoerythrin, or
peridinin chlorophyll protein (Becton Dickinson). A gated lymphocyte popula-
tion was derived from a bivariate histogram display of forward and side scatter
and immunofluorescence data for the T cell populations were quantitated using
the Cell Quest software package (Becton Dickinson). Absolute CD4 and CD8
cell numbers were calculated by the product of the percentage of CD4 and
CD8 cells and the absolute lymphocyte count as determined from a manual
count and confirmed by an automated blood analyzer (Serono-Baker 9018,
Allentown, PA).
Tissue collection and processing All SIVmac239YEnef-infected animals
were examined for the presence of cutaneous rash on days 3, 7, and 14 pi
(Table I). Animals 41–76 and 247–77 were examined more frequently. All
SIVmac239/R17Y-infected animals were examined daily for onset of cutaneous
rash. To characterize the progression of cutaneous rash, six animals (one
infected with SIVmac239/YEnef and five infected with SIVmac239/R17Y)
had sequential skin biopsies taken at the onset of rash and at one or two
additional times within the next 24–72 h (Table II). For a nonrash control, an
additional biopsy was obtained at day 10 pi from the only SIVmac239/R17Y-
infected animal that did not develop clinically evident rash (195–84). In addition,
four uninfected animals without evidence of cutaneous disease were biopsied
and used as normal skin controls. At least two 8 mm punch biopsies were
obtained from each animal while they were anesthetized with Ketamine HCL.
Sections were bisected with one-half fixed in 10% neutral buffered formalin
for histopathologic examination and the remaining half snap-frozen in OCT
Compound (Miles, Elkhart, IN) by immersion in 2-methylbutane cooled in
dry ice for immunohistochemistry. For electron microscopy additional biopsies
were fixed in 3% gluteraldehyde, postfixed in 1% osmium tetroxide (Stevens
Metallurgical, New York, NY), dehydrated, and embedded in eponate 12 resin
(Ted Pella, Redding, CA). All sections were stained with uranyl acetate and
Reynold’s lead citrate and examined on a JEOL 1005 electron microscope.
Localization of SIV-infected cells by in situ hybridization and
immunohistochemistry In situ hybridization was performed with formalin-
fixed paraffin-embedded sections by two separate techniques. The first protocol
performed by Molecular Histology (Gaithersburg, MD) utilized radiolabeled
RNA probes synthesized from five DNA templates covering 90% of the SIV
genome subcloned into pGEM4 as previously described (Fox and Cottler-Fox,
1994). The second protocol used a DNA probe labeled with digoxigenin-11-
dUTP by random priming (Boehringer Mannheim, Indianapolis, IN) as
previously described (Ilyinskii et al, 1994; Sasseville et al, 1996a). This second
technique was combined with immunohistochemistry using the monoclonal
antibody HAM-56 (Dako, Carpinteria, CA) for double-labeling SIV-infected
macrophages. For these procedures the following controls were included: serial
sections of each skin biopsy and known SIV positive and negative tissues were
hybridized with sense or anti-sense radiolabeled RNA probes (technique 1), or
SIV-specific DNA probes or plasmid pUC19 labeled with digoxigenin-11-
dUTP (technique 2).
Sections were examined microscopically and scored semiquantitatively on a
scale of 0–4 as follows (Table II): the absence of in situ positive cells was given
a score of 0; 1–5 positive cells per section a score of 11; 6–15 positive cells
per section a score of 21; 16–30 positive cells per section a score of 31; and
greater than 30 positive cells per section a score of 41 (Table II).
Snap-frozen biopsies were used in immunohistochemical procedures to
localize viral antigen as previously described (Horvath et al, 1993; Ilyinskii et al,
1994). Briefly, tissue sections were fixed in 2% paraformaldehyde immunostained
using an avidin-biotin-horseradish peroxidase complex (ABC) technique with
diaminobenzidine as the chromogen. The primary antibody used was Senv71.1
(C. Colignon, C. Thiriart, SmithKline Beacham, Belgium), which recognizes
SIV gp120.
Immunohistochemistry Formalin-fixed or snap-frozen sections of skin were
used to examine the immunophenotype of cellular infiltrates by an ABC
immunohistochemical technique as previously described (Horvath et al, 1993).
T cells and monocyte/macrophages were identified with formalin-fixed tissues
using the pan-T polyclonal antibody CD3 (Dako) and the monoclonal antibody
HAM-56 (Dako), respectively. Frozen sections were analyzed for T cell subsets
using monoclonal antibodies to CD4 (Nu-Th/I, Nicheri Research Institute,
Japan) and CD8 (DK 25, Dako). In addition, we examined expression of GMP-
17 (TIA-1, Coulter Immunology, Hialeah, FL), which is a marker of cytotoxic
granules in cytolytic CD41 and CD81 T cells, neutrophils, natural killer cells,
and macrophages (Meehan et al, 1997).
Expression of select chemokine receptors and adhesion molecules was
examined to evaluate the leukocyte recruitment mechanisms responsible for
the cellular infiltrates. Chemokine receptor expression was examined in frozen
skin sections by an avidin-biotin-alkaline phosphatase complex technique with
Fast Red (Biogenex, San Ramon, CA) used as the chromogen as previously
described (Rottman et al, 1997). Monoclonal antibodies specific for CCR5 and
CXCR3 were generated and characterized as previously described (Wu et al,
1997; Qin et al, 1998).
Relative levels of cellular activation and proliferation were examined by
immunostaining for the Ki-67 nuclear proliferation antigen (MIB-1, Immuno-
tech, Westbrook, ME) as previously described (Du et al, 1995, 1996; Sasseville
et al, 1996a). The Ki-67 nuclear antigen is specific for proliferating cells found
throughout the cell cycle (G1, S, G2, M phases) and absent in resting (G0)
cells (Landberg et al, 1990; Barbareschi et al, 1994).
Sections immunostained with antibodies directed against CD3, CD4, CD8,
HAM-56, GMP-17, and Ki-67 were examined microscopically and scored
semiquantitatively on a scale of 0–4 as follows: the absence of immunopositive
cells per section was given a score of 0; less than 25% immunopositive cells per
section a score of 11; 25–33% immunopositive cells per section a score of 21;
33–50% immunopositive cells per section a score of 31; and greater than 50%
immunopositive cells per section a score of 41 (Table II).
Snap-frozen skin sections from all animals were also examined for the
adhesion molecules VCAM-1, E-selectin, and αEβ7 (1G11, 1.2B6, and 2G5.1,
respectively, Immunotech) by an ABC immunohistochemical technique.
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Table I. Onset and duration of SIV exanthem
Days post-infectiona
Virus Animal # 3 6 7 8 9 10 12
SIVmac239/YEnef 346-80 –
162-78 –
400-80 – – 11
348-79 – – –
41-76 – – 1111 1111 1111 1111 R
39-82 – – – – – 1 N/Eb
191-85 – – – N/E N/E N/E N/E
189-85 – – – N/E N/E N/E N/E
457-82 – – 1111 N/E N/E N/E N/E
193-85 – – – N/E N/E N/E N/E
247-79 – – 1111 1111 1111 1111 N/E
393-78 – – 11 N/E N/E N/E N/E
SIVmac239/R17Y 163-91 – 11 R R
205-84 – 1111 1111 1111
168-91 – – – 11 11 11
195-84 – – – – –
182-91 – – – 1111 1111
336-84 – – – 1111 R R
aA vertical bar represents the day the animal was euthanized and a complete postmortem examination was performed; all animals were clinically examined and rash was subjectively
quantified on a scale of 0 to 4 as follows: –, within normal limits; 1, minimal; 11, mild; 111, moderate; 1111, severe; R, resolving.
bN/E, not examined.
Table II. Immunophenotypic characterization of SIV exanthem
Days post-infectiona
Virus Animal # 7 8 9 10 12
SIVmac239/YEnef 41-76 Exanthemb 1111 111 1111 1111 R
H&Ec 1111 1111 111
SIV RNAd 1111 1111 111
CD41/CD81e 11/11 11/11
SIVmac239/R17Y 163-91 Exanthem 11 R R
H&E 11 11 1111
SIV RNA 11 – –
CD41/CD81 11/111 1/1111 11/1111
205-84 Exanthem 1111 1111
H&E 1111 1111
SIV RNA 111 1111
CD41/CD81 111/1 111/1
168-91 Exanthem 11 11 11
H&E 111 111
SIV RNA 1 1111
CD41/CD81 111/11 111/111
195-84 Exanthem – – –
H&E 11
SIV RNA –
CD41/CD81 111/11
336-84 Exanthem 1111 R R
H&E 1111 1111 1111
SIV RNA 1111 1 1
CD41/CD81 11/1 11/1 11/11
aA vertical bar represents the day the animal was euthanized and a complete postmortem examination was performed.
bAll animals were clinically examined and rash was subjectively quantified on a scale of 0 to 4 as follows: –, within normal limits; 1, minimal; 11, mild; 111, moderate; 1111,
severe; R, resolving.
cAll animals were examined microscopically and the rash was subjectively quantified on a scale of 0 to 4 as follows: –, within normal limits; 1, minimal; 11, mild; 111, moderate;
1111, severe.
dAll animals were examined microscopically and the rash was subjectively quantified on a scale of 0 to 4 as follows: –, no in situ positive cells; 1, 1 to 5 positive cells per section; 11,
6 to 15 positive cells per section; 111, 16 to 30 positive cells per section; 1111, greater than 30 positive cells per section.
eAll animals were examined microscopically and the rash was subjectively quantified on a scale of 0 to 4 as follows: –, no immunopositive cells per section; 1, ,25% immunopositive
cells per section; 11, 25–33% immunopositive cells per section; 111, 33–50% immunopositive cells per section; 1111, .50% immunopositive cells per
section.
Although skin specific homing of T lymphocytes occurs through the interaction
of E-selectin with cutaneous lymphocyte-associated antigen (CLA) (Picker et al,
1991), we did not have an antibody that recognizes this epitope in rhesus
monkeys. Thus, as αEβ7 is expressed in 50% of intraepithelial lymphocytes and
most αEβ7 positive lymphocytes also express CLA (Spetz et al, 1996), we
examined αEβ7 expression in the skin biopsies. Adhesion molecule expression
on endothelium and perivascular cells was semiquantitatively assessed by using
intensity of immunostaining and distribution of positive cells as criteria as
previously described (Silber et al, 1994; Sasseville et al, 1996c). The numerical
values for the distribution of immunoreactive vessels were as follows: 0, none;
VOL. 110, NO. 6 JUNE 1998 SIV EXANTHEM IN MACAQUES 897
Figure 1. Hematologic values in SIVmac239/YEnef-infected macaques.
CD41 and CD81 lymphopenia corresponds to peak viral burden in tissues
(day 7 pi) followed by CD81 lymphocytosis on days 14 pi. Data at each time
point represent the mean values from all remaining animals (i.e., n 5 12 at day
0; n 5 2 at day 50). Abbreviations are as follows: #WBC, white blood cell
counts; #lymphs, absolute number of lymphocytes; %CD4, CD41 lymphocytes;
% CD8, CD81 lymphocytes.
1, focal; 2, multifocal; 3, diffuse. The scores for staining intensity were: 0,
none; 1, faint; 2, moderate; 3, marked; 4, intense. The product of these two
values for distribution and intensity of positive vessels and cellular infiltrates
(composite score) had a theoretical range of 0–12.
RESULTS
A mild neutrophilia and CD8 lymphocytosis occur during the
first 2 wk of infection Lymphocyte subset analysis by flow cytometry
was limited to the SIVmac239/YEnef-infected animals. These animals
had mildly elevated white blood cell counts (13.3 3 103 per µl)
peaking at day 14, reflecting a mild transient neutrophilia (8.3 3 103
per µl) (Fig 1). In addition, between days 0 and 7 pi mean absolute
lymphocyte numbers decreased by 38%, reflecting a decrease in both
CD4 and CD8 lymphocytes (Fig 1). Between days 7 and 14 pi all
remaining animals had a significant rebound in the numbers of CD8
lymphocytes from a mean of 411 per ul (6 265) on day 7 pi to 2789
per µl (6 1312) on day 14, whereas CD4 lymphocytes remained
decreased from a mean of 550 (6 170) on day 7 pi to 656 (6 282)
on day 14 pi (Fig 1). Although absolute CD4 numbers remained
relatively unchanged, the percentage of CD4 lymphocytes decreased
dramatically due to the marked increase in CD8 lymphocytes (Fig 1).
Maculopapular exanthem was observed in most animals by day
8 pi All animals infected with SIVmac239/YEnef and SIVmac239/
R17Y developed an acute disease syndrome characterized by at least
one of the following: lethargy, lymphadenopathy, diarrhea, and rash as
described previously (Du et al, 1995, 1996; Sasseville et al, 1996a). The
maculopapular rash was observed in five of six animals infected
with SIVmac239/R17Y and in six of the 10 animals infected with
SIVmac239/YEnef that were still alive after day 7 pi (Table I). Severe
generalized rash was first observed by day 6 in one animal (Mm205–
84) and in three additional animals by day 7 pi. Two other animals at
day 7 pi had mild rash limited to the face, neck, and upper torso. By
day 8 pi, four additional animals developed either mild localized or
severe generalized rash. The last animal to develop rash was 39–82,
who developed mild rash limited to the face at day 10 pi. In all cases,
the rash had an acute onset and was characterized by small (2–4 mm)
to large (1 cm) erythematous macules and papules (Fig 2). Two to
three days after the onset of rash occasional macules coalesced to form
larger variably shaped lesions. Some of the larger macules developed
white to yellow crusts within the center of the lesion. Vesicles and
ulcers were never observed. Intense erythema lasted for 2–3 d and
completely resolved by 4 or 5 d after onset. All of the animals were
Figure 2. Cutaneous maculopapular exanthem. Ventral axilla and thorax
(A) and medial aspect of arm (B) displaying multifocal erythematous macules
and papules at day 10 pi with SIVmac239/YEnef.
viremic with SIV as determined by virus isolation from peripheral
blood mononuclear cells.
Histopathology of SIV exanthem resembles HIV exanthem To
examine the development of these lesions, sequential biopsies of skin
were obtained (Table II). On the day rash was first observed, all
biopsies showed similar histopathologic changes characterized by mild
to severe focally extensive dermal inflammation, vascular congestion of
the superficial vascular plexus, endothelial hypertrophy, and perivascular
edema. These infiltrates, which were composed of lymphocytes and
macrophages with lesser numbers of neutrophils, were primarily
localized to vessels in the superficial dermis. In addition, cellular
infiltrates were also occasionally found surrounding hair follicles and
multifocally along the base of the overlying epithelium. Perivascular
and perifollicular neutrophils were more prominent in biopsies obtained
at the onset of rash, but were rare to nonexistent during peak or
resolving rash. Generally, the percentage of macrophages increased
over time in subsequent biopsies. Where infiltrates came in contact
with skin or follicular epithelium, there was mild to moderate acanthosis,
spongiosis, exocytosis, dyskeratosis, and parakeratosis; however, neither
epithelial vesicles nor ulcers were observed. The inflammatory cell
infiltrates and epithelial changes were more intense at the center of
the lesion and dissipated toward the tissue margins. Only mild cellular
infiltrates were observed in the skin biopsy obtained from the SIV-
infected animal without clinically evident rash (195–84, Table II), and
no significant infiltrates were observed in uninfected control animals.
The development of SIV exanthem is associated with abundant
virus positive cells in the dermal perivascular cellular
infiltrates To examine the association of virus with skin rash, we
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Figure 3. Photomicrographs of SIV exanthem at days 7 (A, C, E, G)
and 12 (B, D, F, H) pi with SIVmac239/YEnef. Abundant SIV positive
cells in the perivascular infiltrates from biopsies obtained at rash onset (A) versus
subsequent biopsies (B, arrows). Double-labeling for viral mRNA and the
macrophage marker HAM-56 revealed that most infected cells (A, inset, DAB
black) were not colabeled with HAM-56 (A, inset, DAB brown). By day 12 pi
there was a marked increase in CD8 positive cells (D, inset) and in cells
expressing the chemokine receptor CXCR31 (D), than that observed at day
7 (C). At rash onset, numerous perivascular cells and multifocal aggregates of
intraepithelial cells express αEβ7 (E). At this time, E-selectin is also upregulated
on dermal vessels (E, inset). By day 12, most αEβ7 expressing cells are localized
to the epithelium (F). GMP-17 is absent in the αEβ7 cells trafficking to the
skin at rash onset (G), but is expressed on most of these perivascular cells by
day 12. (A, B) In situ hybridization with hematoxylin and eosin counterstain;
(C, D) ABC technique with Fast Red chromogen and hematoxylin counterstain;
(D inset) in situ hybridization with DAB black chromogen and ABC
immunohistochemical technique with DAB brown chromogen and hematoxylin
counterstain; (E, E inset, F, G, H) ABC technique with DAB brown chromogen
and hematoxylin counterstain.
performed in situ hybridization and immunohistochemistry for viral
nucleic acid and antigen in six of the SIV-infected animals. Five of
these animals had rash evident grossly and one (195–84) never
developed rash.
In SIV-infected animals with cutaneous rash, abundant in situ positive
cells were first observed in the initial biopsies obtained at either day 7
or 8 pi (Table II). Most of the positive cells were found in the
perivascular infiltrates of the superficial dermis (Fig 3A).Occasional
SIV-RNA positive cells were observed within the epidermis overlying
areas of dermal inflammation (Fig 3A). Double-labeling for viral
mRNA and the macrophage marker HAM-56 revealed that most SIV
positive cells did not colabel with the macrophage marker, suggesting
that most infected cells were lymphocytes (Fig 3A, inset). Immunohisto-
chemical expression of gp120 in adjacent skin sections correlated with
viral mRNA expression, but generally fewer positive cells were detected
by immunohistochemistry than by in situ hybridization (data not
shown). Virus was not detected in any of the biopsies by electron
microscopy. Despite mild cellular infiltrates in the dermis of the animal
without clinical rash (195–84), virus was not detected by in situ
hybridization, immunohistochemistry, or electron microscopy. In four
animals, a second biopsy was obtained within 24 h of collecting the
initial biopsy. In two of these animals (163–91, 336–84), viral burden
in the skin, as assessed by semiquantitative microscopic examination,
was substantially decreased or absent. Two of these four animals (168–
91, 205–84) had increased viral burden within 24 h of the initial
biopsy. As both of these animals were killed within 48 h of the onset
of rash, we were unable to assess the progression of rash in these animals.
Cellular infiltrates consist primarily of cytotoxic T cells To
immunophenotype the cellular infiltrates, all biopsies were immuno-
stained with antibodies directed against the T lymphocyte markers
CD3, CD4, and CD8, and the macrophage marker HAM-56. In
addition, we examined the expression of GMP-17, which is a marker
of cytotoxic granules, and Ki-67, a nuclear proliferation antigen. In
animals with rash, the percentage of CD31 lymphocytes in perivascular
and perifollicular infiltrates varied between 25% and . 50% (data not
shown). No significant differences in the percentages were observed
among animals or among biopsies obtained at various times after the
onset of rash. Intraepithelial CD31 cells were most abundant (5–10
per hpf) above dermal infiltrates. In most skin biopsies examined, the
percentage of HAM-56 positive cells in these lesions increased from
less than 25% on initial biopsy to µ50% in subsequent samples (data
not shown). Unlike CD31 lymphocytes that were restricted to
the epithelium overlying dermal infiltrates, numerous intraepithelial
HAM561 cells were observed throughout the epidermis.
Depending on the biopsy examined, the relative proportions of
mononuclear cells immunoreactive with antibodies against CD4 and
CD8 varied considerably among animals (Table II). Among biopsies
from different animals, the range of CD41 and CD81 cell counts
was 25% to 50% and , 25% to . 50%, respectively; however, when
sequential biopsies from the same animal were compared, there was
no significant difference in CD41 cell counts, but in most animals a
marked increase in CD81 lymphocytes was observed between the
initial and subsequent biopsies (Table II, Fig 3D, inset). GMP-17
expression was absent in normal skin and in biopsies obtained at the
onset of rash (Fig 3G); however, GMP-17 immunopositive cells
comprised . 50% of the perivascular cells in subsequent biopsies,
suggesting an influx of cytotoxic cells during the resolution of rash
(Fig 3H).
Cellular infiltrates in SIV exanthem are recruited and proliferate
in vivo CXCR3 is expressed predominantly on activated CD81
lymphocytes (Qin et al, 1998). Thus, as with the percentage increase
in CD81 lymphocytes, expression of the chemokine receptor CXCR3
increased between the initial and subsequent biopsies obtained from
animals with rash (Fig 3C, D). CXCR3 expression was not observed
in control skin from uninfected animals. In these same biopsies, CCR5
expression was generally observed in , 25% of the perivascular
inflammatory cells, but there was no significant difference between the
initial and subsequent biopsies (data not shown). CCR5 expression
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was elevated over the minimal expression observed in control skin
from uninfected animals.
E-selectin expression was moderate to markedly elevated on endothe-
lium in most dermal and subcutaneous vessels in all biopsies examined
on the day of rash onset (Fig 3E, inset), but decreased in most animals
thereafter (data not shown). No E-selectin was observed in normal
skin. We did not have an antibody that recognizes CLA, the ligand
for E-selectin in the skin, but the integrin αEβ7 is coexpressed with
CLA in intraepithelial lymphocytes (Spetz et al, 1996). In normal skin
the expression αEβ7 was restricted to rare intraepithelial lymphocytes,
but in biopsies taken at the onset of rash, αEβ7 expression was observed
in µ50% of the perivascular cells and in many of the intraepithelial
lymphocytes (Fig 3E). In subsequent biopsies αEβ7 expression was
localized to intraepithelial lymphocytes, but was decreased in peri-
vascular inflammatory cells (Fig 3F). Thus, αEβ7 expression on
perivascular inflammatory cells coincided with peak upregulation of
E-selectin on dermal vessels (rash onset), and decreased thereafter.
In contrast to the diffuse E-selectin expression, endothelial VCAM-1
expression was localized to focal vessels within the superficial dermis.
In addition to endothelium, moderate to marked VCAM-1 expression
was observed on cells morphologically compatible with dendritic cells
and perivascular macrophages within the dermis in all samples (data
not shown).
Ki-67 immunoreactivity in unaffected skin adjacent to dermal lesions
was localized to isolated epithelial cells in the stratum basale and
external root sheath of hair follicles with few or no positive cells in
the dermis. In areas with dermal inflammation, the overlying acanthotic
epithelium had intense and diffuse expression on all cells within the
stratum basale and in the external root sheath of hair follicles and the
germinative zones of sebaceous glands (data not shown). Twenty-five
to 50% of the perivascular infiltrates were immunopositive for Ki-67,
suggesting in situ proliferation. There was no correlation between
percentage of cells immunopositive for Ki-67, time pi, intensity of
inflammation, or presence of viral RNA or protein.
DISCUSSION
In this study, we utilized the SIV-infected macaque model of AIDS to
investigate the pathogenesis of the exanthem associated with acute
HIV-1 infection. The rash observed in SIVmac239/YEnef and
SIVmac239/R17Y-infected animals consisted of mild-to-moderate vas-
cular congestion in the superficial vascular plexus, endothelial hyper-
trophy, perivascular edema, and lymphocytic perivascular cuffs similar
to that described in detail previously for HIV and SIV exanthem
(Ringler et al, 1986, 1987; McMillan et al, 1989; Balslev et al, 1990;
Hulsebosch et al, 1990; Clark et al, 1991; Lapins et al, 1996). Sequential
skin biopsies were obtained from rhesus monkeys with rash resulting
from infection with SIVmac239/YEnef and SIVmac239/R17Y. In
biopsies obtained at the onset of rash, we observed elevated expression
of E-selectin, abundant SIV nucleic acid and protein, and αEβ7 positive
perivascular lymphocytes compatible with increased recruitment of
activated T cells to the skin very early after infection with SIV.
Moreover, we demonstrated that clearance of virus from the skin and
resolution of rash were associated with an increase in inflammatory
cells expressing CD8, cytotoxic granules (GMP-17), and the chemokine
receptor CXCR3.
Although viremia is associated with the onset of HIV exanthem
(Clark et al, 1991; Daar et al, 1991), the direct role of dermal invasion
by HIV in the pathogenesis remains speculative (McMillan et al, 1989;
Duvic, 1995; Lapins et al, 1996). In fact, there is only a single report
in the literature demonstrating HIV p24 antigen in perivascular
inflammatory cells from a patient with rash arising 10 d after HIV-1
exposure (McMillan et al, 1989). Likewise, studies in macaques infected
with other isolates of SIV failed to detect virus within the epithelium
or in the perivascular inflammatory cells (Ringler et al, 1986, 1987;
Baskin et al, 1988). In contrast, we demonstrated abundant SIV in the
dermal infiltrates, which supports the role of virus-infected cells in the
development of cutaneous rash. Moreover, resolution of the rash is
associated with decreased cutaneous viral burden, despite abundant
viral load in these same animals in the gastrointestinal tract and
lymphoid tissues (Du et al, 1995, 1996; Sasseville et al, 1996a). Thus,
the presence of virus in the skin most likely precipitates clinically
evident cutaneous exanthem in SIV-infected macaques.
We hypothesize that there is increased recruitment of activated
lymphocytes to the skin and localized lymphocyte proliferation (Ki-
671) serving as a source for viral replication during acute stages of
SIV infection. Early in HIV and SIV infection, virus localizes in
lymphoid tissues, which have an abundant source of activated target
cells (Biberfeld et al, 1986; Chakrabarti et al, 1994; Lackner et al, 1994).
Similar to lymph node and gastrointestinal lymphoid tissues, the skin
contains antigen presenting cells (dendritic cells), cytokine producing
cells (keratinocytes), and skin tropic T cells of the memory phenotype
supporting the concept of skin-associated lymphoid tissue (Streilein,
1990; Memar et al, 1995). Moreover, the skin contains abundant
microvessels within the superficial dermis, which have been shown to
express adhesion molecules and chemokines imperative for directed
cell trafficking (Walsh et al, 1990; Picker et al, 1991; Silber et al, 1994;
Rand et al, 1996). In this regard, E-selectin has been shown to be an
important adhesion molecule in the homing of CLA positive memory
T cells to sites of cutaneous inflammation (Picker et al, 1991). Thus,
similar to the mucosal addressin MAdCAM and the peripheral lymph
node vascular addressin PNAd (Streeter et al, 1988), E-selectin serves
as a skin vascular addressin (Picker et al, 1991). In agreement with the
findings of Silber et al (1994), demonstrating E-selectin expression in
two different cutaneous inflammatory models in rhesus monkeys, we
also observed prominent E-selectin expression on dermal vasculature
in all of the skin biopsies taken from animals at onset of rash. We were
unable to confirm the presence of CLA on the perivascular T cell
infiltrates in these tissues as the murine antibodies directed against the
human CLA antigen did not recognize the epitope in rhesus monkeys,
but these cells did express αEβ7 that is coexpressed with CLA on
intraepithelial lymphocytes (Spetz et al, 1996). Thus, the presence of
αEβ7 positive cells associated with peak endothelial E-selectin in
biopsies obtained at the onset of rash suggest that, as in lymph node
and gastrointestinal lymphoid tissues, there is increased recruitment of
activated lymphocytes to the skin in response to antigenic stimuli
during acute SIV infection.
Whether or not there is selective recruitment of viral infected
lymphocytes or infection of CD41 cells once they arrive at the sites
of inflammation cannot be determined from this study; however, the
multifocal distribution of isolated virus positive cells in the perivascular
infiltrates suggests the former. Previous observations by us have
suggested that virus positive cells readily traffic to sites of preexisting
inflammation early after SIV infection (Sasseville et al, 1996b), but do
not during late-stage disease (Horvath et al, 1993; Sasseville et al, 1995).
In addition to increased recruitment of lymphocytes to the skin, the
presence of abundant Ki-67 immunopositivity suggests lymphocyte
proliferation at these sites. The finding of increased endothelial adhesion
molecules and Ki-67 supports our previous hypothesis that SIV
mac239YEnef-induced lesions are the result of increased recruitment
and also proliferation of leukocytes providing a continuous source of
activated cells available for viral replication (Sasseville et al, 1996a).
In addition to elevated adhesion molecule expression on microvascu-
lar endothelium, leukocytes are also activated and migrate in response
to chemotactic gradients elicited from inflammatory sites (Springer,
1994). The chemotactic stimuli responsible for lymphocyte recruitment
to the skin in HIV/SIV exanthem are unknown, but select chemokines
have been shown to be elevated in tissues with HIV and SIV-induced
inflammation (Sasseville et al, 1996c; Schmidtmayerova et al, 1996;
Tedla et al, 1996; Zou et al, 1997). The CXC chemokines interferon-
inducible protein-10 (IP-10) and Mig are potent chemoattractants of
activated T cells via the chemokine receptor CXCR3 (Loetscher et al,
1996), and IP-10 has been shown to be expressed on interferon-γ-
induced microvascular endothelial cells (Goebeler et al, 1997). Thus,
we examined these infiltrates for immunohistochemical expression of
CXCR3. Between the time of initial biopsy taken at onset of rash and
subsequent samples, we found that there was a marked increase in the
percentage of CXCR3 positive cells. Although double labeling for
CD81 and CXCR31 in skin biopsies was not done, we have
demonstrated that CXCR3 is coexpressed on CD81 T cells and
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absolute numbers of CD81 lymphocytes and CXCR31 lymphocytes
rise in parallel in peripheral blood and lymph nodes in rhesus monkeys
infected with the pathogenic molecular clones SIVmac239 and
SIVmac239/316 (data not shown). Moreover, we observed an associ-
ation between increased perivascular cells expressing GMP-17 and
resolution of rash. It is also known that a rapid cytotoxic T lymphocyte
response occurs within days of SIV and HIV-1 infection and is
associated with a decrease in viral loads (Reimann et al, 1991 , 1994;
Jassoy et al, 1992; Yasutomi et al, 1993; Joag et al, 1994; Safrit et al,
1994; Gallimore et al, 1995). In this study, SIVmac239YEnef-infected
animals had a 2-fold rebound in the absolute number and percentage
of CD81 peripheral blood lymphocytes between days 7 and 14 pi.
Interestingly, this is the time in which increased CD81 and CXCR31
lymphocytes were observed in the skin infiltrates. This early peak in
CD81 lymphocytes is unique in that peak lymphocytosis is generally
observed around day 21 pi with other pathogenic isolates of SIV
(Reimann et al, 1994). These results suggest that activated CXCR31 T
cells readily traffic to the skin and may directly or indirectly affect
levels of viral replication at these sites.
In addition to their roles in chemoattraction, certain chemokine
receptors have recently been shown to serve as coreceptors along with
CD4 for infection of target cells by both HIV and SIV (Alkhatib et al,
1997; Chen et al, 1997; Deng et al, 1997; Edinger et al, 1997; Marcon
et al, 1997). Because one of these chemokine receptors termed CCR5
is utilized by macrophage-tropic (M-tropic) HIV-1 strains (Alkhatib
et al, 1996; Choe et al, 1996; Deng et al, 1996; Dragic et al, 1996), as
well as both M-tropic and T cell tropic strains of SIV (Chen et al,
1997; Edinger et al, 1997; Marcon et al, 1997), we examined its
expression in the skin. CCR5 expression was elevated over that
observed in normal skin from uninfected animals, but never reached
the level of expression of CXCR3. As it has been shown that CCR5
is expressed by macrophages and the effector/memory subset of T cells
(Wu et al, 1997), it is possible that enhanced recirculation of previously
activated lymphocytes from the peripheral blood to the skin may occur
early in SIV infection. This pool of activated CD41 cells expressing
CCR5 may serve as a source for early rounds of viral replication. In
addition to CCR5, it has been shown that M-tropic HIV-1, HIV-2,
and SIV also use two newly described G-protein-coupled receptors,
termed Bonzo (STRL33) and BOB (Alkhatib et al, 1997; Deng et al,
1997). The expression of these two novel receptors has not been
examined in the skin.
By using the molecular clones of SIVmac239/YEnef and
SIVmac239/R17Y that cause an exaggerated acute disease syndrome
in rhesus monkeys, we were able to unravel some of the mysteries
concerning the pathogenesis of HIV exanthem. The increased expres-
sion of E-selectin, a putative skin-associated lymphoid tissue addressin,
and the abundance of αEβ7 perivascular lymphocytes, suggest that
there is increased recruitment of activated T cells to the skin very early
after infection. The presence of activated CD41/CCR51 lymphocytes
along with increased local lymphoid proliferation (Ki-67 positive), may
serve as the nidus for viral invasion of the skin similar to that observed
in lymph nodes and gut associated lymphoid tissue. In biopsies obtained
during resolution of rash, the increase in CD81, CXCR31, and
GMP-171 cells trafficking to the skin is likely to be responsible for
the decreased viral burden in the skin.
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